• Post Operative0
• Adjuvant0

• Protocols

• RTOG1216

  OPEN TO ACCRUAL

  PhII/III Cisplatin vs. Docetaxel-Cetuximab vs. Cisplatin-Atezolizumab for High Risk H&N
  
  

• UW21144

  OPEN TO ACCRUAL

  Phase 1 + dose expansion of MSC in patients with Xerostomia post RT In H&N cancer
  
  

• UW23121

  OPEN TO ACCRUAL

  Pilot Study of INCB081776